免疫血液学市场规模、份额和成长分析（按产品、最终用途、技术和地区划分）－2026-2033年产业预测

预计到 2024 年，免疫血液学市场规模将达到 20.1 亿美元，到 2025 年将达到 21 亿美元，到 2033 年将达到 30.2 亿美元，在预测期（2026-2033 年）内，复合年增长率为 4.63%。

受技术进步和创新产品推出的推动，免疫血液学市场预计将迎来显着成长。医院和研究机构的一个显着趋势是转向使用自动化设备，以提升营运效率，并采用多功能平台。白血病、贫血和各种出血性疾病等血液相关疾病发生率的上升，推动了对高效血液检测的需求。研发投入的大幅增加、医疗政策的强化以及政府的支持性政策，以及其他因素，进一步提振了产业前景。此外，大量评估自动化免疫血液学检查设备准确性和有效性的研究证实，需要精准的诊断方法来应对日益增多的血液疾病，确保市场在不久的将来持续强劲增长。

免疫血液学市场驱动因素

全球免疫血液学市场的主要驱动因素之一是血友病、地中海贫血和镰状贫血等血液疾病的日益普遍，这些疾病需要先进的血液检测和输血管理。对安全且相容的血液製品的需求不断增长，推动了尖端免疫血液学技术的发展，从而有助于改善患者照护和治疗效果。此外，择期手术和创伤相关手术的增加也进一步推动了对高效输血服务的需求。随着医疗系统致力于提高输血的安全性和有效性，免疫血液学领域的创新也不断推动市场扩张和投资。

免疫血液学市场限制因素

影响全球免疫血液学市场的关键限制因素之一是严格的血液安全和产品核可监管环境。这些监管程序的复杂性和冗长性会减缓新技术和创新成果的引入，从而抑制该领域的投资和研发。此外，不同地区的监管差异会使国际公司进入市场更加复杂，导致营运成本增加和市场分散。这些障碍会阻碍整体市场成长，限制先进免疫血液学产品和服务的获取，进而影响医疗机构及时有效地提供输血和诊断解决方案的能力。

免疫血液学市场趋势

免疫血液学市场正呈现出一个显着的趋势，即开发和应用专注于个人化医疗和学名药的先进技术。关键创新包括改进罕见血型抗原的检测方法，这些方法优化了输血通讯协定，并实现了根据患者个体特征量身定制的输血。这项转变得益于基因分型和分子诊断技术研发投入的增加，这些技术能够揭示复杂的血型模式。随着医疗保健向精准医疗发展，这些进步不仅改善了患者的治疗效果，还简化了输血流程，为免疫血液学领域的显着增长和发展奠定了基础，使其能够不断演进以满足动态的临床需求。

目录

介绍

• 调查目标
• 定义
• 市场覆盖范围

调查方法

• 资讯收集
• 二手和一手资讯来源
• 市场规模预测
• 市场假设与限制

执行摘要

前景
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场动态
  • 司机
  • 机会
  • 抑制因素
  • 任务
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 技术分析
• 监管环境
• 专利分析
• PESTEL 分析
• 案例研究分析

免疫血液学市场：依产品分类

• 免疫血液分析仪
• 免疫血液学试剂

免疫血液学市场：依最终用途划分

• 医院
• 血库
• 诊断检查室

免疫血液学市场规模：按地区划分

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲（MEA）
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争格局

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市占率（2025 年）

主要企业简介

• Grifols
• QuidelOrtho
• Immucor
• Bio-Rad Laboratories
• Beckman Coulter
• Novartis
• Quotient Limited
• Diagast
• Becton, Dickinson and Company
• Thermo Fisher Scientific
• Abbott Laboratories
• BioMerieux
• Hologic, Inc.
• Werfen SA
• Merck KGaA
• DiaSorin SpA
• F. Hoffmann-La Roche AG
• Immucor Gamma Biologics
• Tulip Diagnostics Pvt. Ltd.
• Versiti

Immunohematology Market size was valued at USD 2.01 Billion in 2024 and is poised to grow from USD 2.1 Billion in 2025 to USD 3.02 Billion by 2033, growing at a CAGR of 4.63% during the forecast period (2026-2033).

The immunohematology market is poised for substantial growth, propelled by technological advancements and innovative product launches. A notable trend among hospitals and research institutions is the transition to automated instrumentation, with a preference for multifunctional platforms that streamline operations. The rising incidence of blood-related disorders, including leukemia, anemia, and various hemorrhagic diseases, fuels the demand for efficient hematological testing. Significant increases in research and development funding, along with enhanced healthcare initiatives and favorable government policies, further bolster industry prospects. Additionally, extensive research assessing the accuracy and efficacy of automated immunohematology analyzers underscores the necessity for precise diagnostics in addressing the escalating prevalence of blood disorders, ultimately positioning the market for robust expansion in the foreseeable future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Immunohematology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Immunohematology Market Segments Analysis

Global Immunohematology Market is segmented by Product, End Use, and region. Based on Product , the market is segmented into Immunohematology analyzer, Immunohematology reagent. Based on End Use, the market is segmented into Hospitals, Blood banks, Diagnostic laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Immunohematology Market

One of the key market drivers for the global immunohematology market is the increasing prevalence of blood disorders, such as hemophilia, thalassemia, and sickle cell anemia, which necessitate advanced blood testing and transfusion practices. The rising demand for safe and compatible blood products has led to the development of sophisticated immunohematology techniques, enhancing patient care and outcomes. Additionally, the growth in elective surgeries and trauma-related procedures further drives the requirement for efficient blood transfusion services. As healthcare systems focus on improving the safety and efficacy of blood transfusions, innovations in immunohematology continue to propel market expansion and investment.

Restraints in the Immunohematology Market

One significant restraint affecting the global immunohematology market is the stringent regulatory landscape governing blood safety and product approval processes. The complexity and length of these regulatory procedures can delay the introduction of new technologies and innovations, discouraging investment and development in the sector. Additionally, varying regulations across regions can complicate market entry for international companies, resulting in increased operational costs and potential market fragmentation. These barriers can hinder overall market growth and limit access to advanced immunohematology products and services, affecting healthcare providers' ability to deliver timely and effective blood transfusion and diagnostic solutions.

Market Trends of the Immunohematology Market

The immunohematology market is witnessing a notable trend towards the development and adoption of advanced technologies focusing on personalized medicine and generic medications. Key innovations include enhanced methodologies for detecting rare blood group antigens, ultimately refining blood transfusion protocols to better match individual patient profiles. This shift is supported by increased investments in research and development of genotyping and molecular diagnostics that elucidate intricate blood group patterns. As healthcare moves towards precision medicine, these advancements not only improve patient outcomes but also streamline transfusion processes, positioning the immunohematology sector for significant growth and evolution in response to dynamic clinical needs.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Technology Analysis
• Regulatory Landscape
• Patent Analysis
• PESTEL Analysis
• Case Study Analysis

Immunohematology Market, By Product

• Market Overview
• Immunohematology analyzer
• Immunohematology reagent

Immunohematology Market, By End Use

• Market Overview
• Hospitals
• Blood banks
• Diagnostic laboratories

Immunohematology Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2025

Key Company Profiles

• Grifols
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Immucor
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quotient Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diagast
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Werfen S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Immucor Gamma Biologics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tulip Diagnostics Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Versiti
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments